Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matejka Rebolj

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Nature Reviews. Clinical Oncology|November 11, 2009
Primary HPV screening for cervical cancer prevention: results from European trialsElsebeth Lynge, Matejka Rebolj
Asian Pacific Journal of Cancer Prevention : APJCP|January 29, 2010
Challenges to cervical screening in a developing country: The case of MalaysiaNor Hayati Othman, Matejka Rebolj
Expert Review of Anticancer Therapy|August 3, 2011
Human papillomavirus testing and genotyping in cervical screeningMatejka Rebolj, Elsebeth Lynge, Jesper Bonde
International Journal of Cancer|January 24, 2023
Managing an extension of screening intervals: Avoiding boom and bust in health care workloadsFrancesca Pesola, Matejka Rebolj, Peter Sasieni
European Journal of Cancer (Oxford, England : 1990)|September 14, 2010
False-positive Human Papillomavirus DNA tests in cervical screening: it is all in a definitionMatejka Rebolj, Igor Pribac, Elsebeth Lynge
Journal of Medical Screening|October 4, 2018
Is a delay in the introduction of human papillomavirus-based cervical screening affordable?Alejandra Castañon, Matejka Rebolj, Peter Sasieni
BMC Cancer|April 18, 2015
Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: a split-sample studyDitte Møller Ejegod, Matejka Rebolj, Jesper Bonde
Cancer Cytopathology|April 4, 2022
Cytology interpretation after a change to HPV testing in primary cervical screening: Observational study from the English pilotMatejka Rebolj, Christopher S Mathews, Karin Denton, et al.
International Journal of Cancer|April 11, 2018
As you like it: How the same data can support manifold views of overdiagnosis in breast cancer screeningSisse Helle Njor, Eugenio Paci, Matejka Rebolj
International Journal of Cancer|November 30, 2013
Mortality of non-participants in cervical screening: Register-based cohort studyPierre-Antoine Dugué, Elsebeth Lynge, Matejka Rebolj
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Nature Reviews. Clinical Oncology|November 11, 2009
Primary HPV screening for cervical cancer prevention: results from European trialsElsebeth Lynge, Matejka Rebolj
Asian Pacific Journal of Cancer Prevention : APJCP|January 29, 2010
Challenges to cervical screening in a developing country: The case of MalaysiaNor Hayati Othman, Matejka Rebolj
Expert Review of Anticancer Therapy|August 3, 2011
Human papillomavirus testing and genotyping in cervical screeningMatejka Rebolj, Elsebeth Lynge, Jesper Bonde
International Journal of Cancer|January 24, 2023
Managing an extension of screening intervals: Avoiding boom and bust in health care workloadsFrancesca Pesola, Matejka Rebolj, Peter Sasieni
European Journal of Cancer (Oxford, England : 1990)|September 14, 2010
False-positive Human Papillomavirus DNA tests in cervical screening: it is all in a definitionMatejka Rebolj, Igor Pribac, Elsebeth Lynge
Journal of Medical Screening|October 4, 2018
Is a delay in the introduction of human papillomavirus-based cervical screening affordable?Alejandra Castañon, Matejka Rebolj, Peter Sasieni
BMC Cancer|April 18, 2015
Comparison of analytical and clinical performance of CLART HPV2 genotyping assay to Linear Array and Hybrid Capture 2: a split-sample studyDitte Møller Ejegod, Matejka Rebolj, Jesper Bonde
Cancer Cytopathology|April 4, 2022
Cytology interpretation after a change to HPV testing in primary cervical screening: Observational study from the English pilotMatejka Rebolj, Christopher S Mathews, Karin Denton, et al.
International Journal of Cancer|April 11, 2018
As you like it: How the same data can support manifold views of overdiagnosis in breast cancer screeningSisse Helle Njor, Eugenio Paci, Matejka Rebolj
International Journal of Cancer|November 30, 2013
Mortality of non-participants in cervical screening: Register-based cohort studyPierre-Antoine Dugué, Elsebeth Lynge, Matejka Rebolj
Pageof 9